|
Perhaps the government should buy the drug and force the company to sell if necessary. And then it should find a permanent place in reseach and development in order to develop and distribute drugs to those who need them.
The goal should be to get the drug on the market and treat the disease.
This provides a very good argument that there are some things that government can do better than private industry. Good examples are the delivery of water and power, the postal system and health care. This would appear to be a instance where the free market has failed consumers. Instead of defending the free market as the be all and end all of civil society, we might want to entertain the notion that health care is too important is too important to be left to a free market that suffers from a lack of competition due to corporate largesse.
People who suffer from Parkinson Disease may benefit from this drug and, assuming that it is safe and effective, shouldn't be denied it because Amgen won't make a profit from it. That may be good business, but it's bad medicine and poor public policy.
Private industry works best when business are small and competitive. The competition in the market place among businesses fosters better service and innovation and has been the raison d'etre of capitalism. In such an environment, the government would do more harm than good intervening in the market place. Of course, in such an environment, if Amgen can't produce a drug that would benefit those with Parkinson's Disease and find a profitable way to market it, somebody else probably will.
In an age of corporate largesse, there isn't enough competition to justify laissez faire policies. Corporations don't need to compete if there are only a handful of them that control the market. In that kind of environment, the businesses don't need to concern themselves about providing the best product to their customers because consumers either take what they provide or go without. A competitor with a better mouse trap can be bought out by a large corporation, which will then make the decision whether it can be profitably marketed. In this way, corporate largesse works against competition and innovation while continuing to promote such virtues as their raison d'etre.
|